A pre-commercial pharma preparing for its first U.S. launch faced gaps in compliance infrastructure and limited internal expertise. IQVIA designed and implemented a tailored compliance program, covering risk assessment, policy development, training, FMV analysis, HCP engagement processes, transparency reporting, and interim compliance office support. Delivered under tight timelines, the solution enabled rapid program development, reduced leadership burden, and provided cost-effective access to broad compliance expertise. Seamless integration with launch activities and ongoing expert support ensured a robust, scalable system, positioning the client for compliant and confident market entry.

Join for free to read